ArticleJournal of neuro-oncology2018

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.

Signe Regner Michaelsen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.